Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-000764
Filing Date
2023-05-01
Accepted
2023-05-01 16:29:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5614
  Complete submission text file 0001959173-23-000764.txt   6967
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38365 | Film No.: 23874155
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Reporting) CIK: 0001728916 (see all company filings)

Type: 144